InVivo Therapeutics (NSDQ:NVIV) said today that the FDA cleared an expansion of its Inspire study of its neuro-spinal scaffold, now set to enroll up to 20 patients, and announced the 9th and 10th implantation in the trial, though the 10th patient died of an unrelated stroke. The Cambridge, Mass.-based company’s neuro-spinal scaffold is surgically implanted following acute spinal […]
Spine
Mazor unveils Mazor X robotic spinal surgery platform
Mazor Robotics (NSDQ:MZOR) today unveiled its Mazor X robotic spinal surgery system, designed to combine analytical tools, precision guidance, optical tracking and intra-operative verification into a single, spinal surgical aid system. The Mazor X is slated to launch during the North American Spine Society’s annual meeting in Boston in October, the Israeli company said. “What we […]
Titan Spine wins new Medicare code
Titan Spine said today it won a new technology ICD-10 code from the U.S. Centers for Medicare & Medicaid Services, which allows for nanotextured surfaces on interbody fusion devices, clearing its nanoLOCK surface technology for coverage. The code, approved as an XRG code, will go into effect and be usable on October 1 this year, and came based […]
Amedica closes $13m offering
Amedica (NSDQ:AMDA) said today it closed its most recent underwritten public offering, bringing in $12.7 million to support its silicone nitride implants. The Salt Lake City, Utah-based company sold a total of 3.6 million Class A units comprised of 1 share of common stock and 1 warrant to purchase 1 share of common stock and […]
Merit Medical pays $98m for DFine’s spine devices
Merit Medical (NSDQ:MMSI) said today that it paid $97.5 million in cash to acquire DFine and created a new division to incorporate DFine’s spine devices. San Jose, Calif.-based DFine makes the StabiliT line of devices, for injecting bone cement into vertebral fractures, and the Star spine tumor ablation system. Jordan, Utah-based Merit said its new interventional oncology […]
Amedica prices $11m offering
Amedica (NSDQ:AMDA) said today that it priced a stock offering worth $11 million for the silicon nitride implants it makes. Salt Lake City, Utah-based Amedica said it plans to float more than 3.6 million shares of common stock at $1 apiece, plus nearly 7,400 preferred shares at $1,000 each, and 11 million warrants. The common stock […]
NuVasive closes $98m Biotronic NeuroNetwork buyout
NuVasive Inc. (NSDQ:NUVA) said today that it closed the $98 million acquisition of intraoperative neurophysiological monitoring service provider Biotronic NeuroNetwork. Ann Arbor, Mich.-based Biotronic NeuroNetwork provides neurophysiological monitoring services to surgeons and healthcare facilities in the U.S., as well as remote physician oversight. The company supports more than 45,000 surgeries annually at more than 650 hospitals, NuVasive […]
NuVasive ponies up $45m to settle Medtronic beef
NuVasive Inc. (NSDQ:NUVA) said yesterday that it agreed to pay Medtronic (NYSE:MDT) $45 million to settle their long-running patent infringement beef. The companies expect to reach a final agreement within 15 days, putting to rest a battle that began when Medtronic subsidiary Warsaw Orthopedic sued NuVasive in 2008. San Diego-based NuVasive counter-sued; in September 2011 a jury […]
InVivo Therapeutics touts case study in 1st spine scaffold implant
InVivo Therapeutics (NSDQ:NVIV) this week touted a case study of the 1st implantation of its spinal scaffold, a bioresorbable device designed to help treat traumatic spinal cord injuries. The study, published in Neurosurgery, the journal of the Congress of Neurological Surgeons, involved a 25-year-old man with an American Spinal Injury Assn. Grade A spinal cord injury sustained in a […]
Centinel Spine wins Australian clearance for Stalif L implant
Centinel Spine said yesterday it won Australian Therapeutic Goods Administration clearance for its Stalif L no-profile lateral lumbar integrated interbody system. Centinel Spine touts the Stalif L as the only lateral device to offer a no-profile, compressive lag fixation device with proprietary anti-backout technology and 12-degrees of lordosis, as well as a large chamber for bone […]
Trial slated in wrongful death suit over Norian XR bone cement
A state court in Washington is slated next week to hear the 1st trial in a group of civil lawsuits filed by the families of patients who died on the operating table minutes after injection with the Norian XR bone cement then made by now-Johnson & Johnson (NYSE:JNJ) subsidiary Synthes. At least 5 patients died during […]